AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
ONDANSETRON
153 registrations across 13 African markets— 133 active
Markets with ONDANSETRON
🇺🇬Uganda
30 registrations
30 active
🇲🇦Morocco
29 registrations
29 active
🇬🇭Ghana
22 registrations
22 active
🇿🇦South Africa
16 registrations
10 active
🇹🇿Tanzania
12 registrations
12 active
🇨🇮Côte d'Ivoire
9 registrations
4 active
🇰🇪Kenya
9 registrations
9 active
🇲🇬Madagascar
8 registrations
8 active
🇲🇼Malawi
7 registrations
0 active
🇳🇬Nigeria
5 registrations
5 active
🇿🇼Zimbabwe
3 registrations
3 active
🇷🇼Rwanda
2 registrations
0 active
🇸🇳Senegal
1 registration
1 active
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Ondansetron Orodispersible Tablets 8 mg Orodispersible Tablet | 🇰🇪Kenya | CIPLA LIMITED | active | Jun 2031 |
| Ondansetron Orodispersible Tablets 4 mg Orodispersible Tablet | 🇰🇪Kenya | CIPLA LIMITED | active | Jun 2031 |
| NAUSTRON 8 SOLUTION FOR INJECTION (Each 4 ml contains Ondansetron 8mg/4ml) | 🇬🇭Ghana | — | active | Mar 2031 |
| NAUSTRON 4 SOLUTION FOR INJECTION (Each 2 ml contains Ondansetron 4mg/2ml) | 🇬🇭Ghana | — | active | Mar 2031 |
| NAUSTRON 4 SOLUTION FOR INJECTION (Each 2 ml contains Ondansetron 4mg/2ml) | 🇬🇭Ghana | — | active | Mar 2031 |
| NAUSTRON 8 SOLUTION FOR INJECTION (Each 4 ml contains Ondansetron 8mg/4ml) | 🇬🇭Ghana | — | active | Mar 2031 |
| ON.SETRON-DENK 8MG ODT TABLETS (Each orodispersible tablet contains Ondansetron 8mg) | 🇬🇭Ghana | — | active | Feb 2031 |
| ON.SETRON-DENK 4MG ODT TABLETS (Each orodispersible tablet contains Ondansetron 4mg) | 🇬🇭Ghana | — | active | Feb 2031 |
| ON.SETRON-DENK 4MG ODT TABLETS (Each orodispersible tablet contains Ondansetron 4mg) | 🇬🇭Ghana | — | active | Feb 2031 |
| ON.SETRON-DENK 8MG ODT TABLETS (Each orodispersible tablet contains Ondansetron 8mg) | 🇬🇭Ghana | — | active | Feb 2031 |
| ONDANEP Injection | 🇰🇪Kenya | NESHER PHARMA LTD | active | Dec 2030 |
| EMITINO 4MG TABLETS (Each uncoated tablet contains Ondansetron 4mg) | 🇬🇭Ghana | — | active | Aug 2030 |
| EMITINO 4MG TABLETS (Each uncoated tablet contains Ondansetron 4mg) | 🇬🇭Ghana | — | active | Aug 2030 |
| Sam Ondansetron Orally Disintegrating Tablets_ Tablet | 🇳🇬Nigeria | Sam Pharmaceutical Limited | active | May 2030 |
| EMITINO-4 INJ INJECTION | 🇬🇭Ghana | — | active | Oct 2029 |
| EMITINO-4 INJ INJECTION | 🇬🇭Ghana | — | active | Oct 2029 |
| ONSETT 8 TABLETS | 🇬🇭Ghana | CADILA HEALTHCARE PHARMACEUTICALS LIMITED; 1389 DHOLKA 387810 DISTRICT AHMEDAHAD GUJARAT STATE INDIA | active | Sept 2029 |
| ONSETT 8 TABLETS | 🇬🇭Ghana | CADILA HEALTHCARE PHARMACEUTICALS LIMITED; 1389 DHOLKA 387810 DISTRICT AHMEDAHAD GUJARAT STATE INDIA | active | Sept 2029 |
| ONSETT 4 TABLETS | 🇬🇭Ghana | CADILA HEALTHCARE PHARMACEUTICALS LIMITED; 1389 DHOLKA 387810 DISTRICT AHMEDAHAD GUJARAT STATE INDIA | active | Sept 2029 |
| ONSETT 4 TABLETS | 🇬🇭Ghana | CADILA HEALTHCARE PHARMACEUTICALS LIMITED; 1389 DHOLKA 387810 DISTRICT AHMEDAHAD GUJARAT STATE INDIA | active | Sept 2029 |
| ONSETT 4 TABLET, COATED; ORAL | 🇿🇼Zimbabwe | CADILA PHARMACEUTICALS LIMITED | active | Jul 2029 |
| ONSETT 8 TABLET, COATED; ORAL | 🇿🇼Zimbabwe | CADILA PHARMACEUTICALS LIMITED | active | Jul 2029 |
| ONDANSETRON 4 ODT AUSTELL | 🇿🇦South Africa | Austell Pharmaceuticals (Pty) Ltd | active | Jun 2029 |
| ZOLFREMET 4 ODT | 🇿🇦South Africa | Austell Pharmaceuticals (Pty) Ltd | active | Jun 2029 |
| ZOFREMET 8 ODT | 🇿🇦South Africa | Austell Pharmaceuticals (Pty) Ltd | active | Jun 2029 |
| ONDANSETRON 8 ODT AUSTELL | 🇿🇦South Africa | Austell Pharmaceuticals (Pty) Ltd | active | Jun 2029 |
| ONSETT TABLET | 🇬🇭Ghana | — | active | Jun 2029 |
| ONSETT TABLET | 🇬🇭Ghana | — | active | Jun 2029 |
| EMITINO 2MG/5ML SOLUTION BUVABLE FLACON DE 30 ML | 🇨🇮Côte d'Ivoire | CACHET PHARMACEUTICALS | active | Mar 2029 |
| NAUSTRON 4 SOLUTION FOR INJECTION (EACH 4ML CONTAINS ONDANSETRON 8MG/4ML | 🇬🇭Ghana | — | active | Mar 2029 |
| NAUSTRON 4 SOLUTION FOR INJECTION (EACH 4ML CONTAINS ONDANSETRON 8MG/4ML | 🇬🇭Ghana | — | active | Mar 2029 |
| NAUSTRON 4 SOLUTION FOR INJECTION (EACH 4ML CONTAINS ONDANSETRON 8MG/4ML | 🇬🇭Ghana | — | active | Mar 2029 |
| NAUSTRON 4 SOLUTION FOR INJECTION (EACH 4ML CONTAINS ONDANSETRON 8MG/4ML | 🇬🇭Ghana | — | active | Mar 2029 |
| SETRONAX 2MG/5ML SIROP FLACON DE 60ML | 🇨🇮Côte d'Ivoire | STRIDES PHARMA SCIENCE LIMITED | active | Jul 2028 |
| ODANSON-4 Tablet | 🇰🇪Kenya | Unison Pharmaceuticals Private Limited | active | Jun 2028 |
| ODANSON-8 Tablet | 🇰🇪Kenya | Unison Pharmaceuticals Private Limited | active | Jun 2028 |
| ONDI SOLUTION | 🇿🇼Zimbabwe | SAKAR HEALTHCARE PVT LTD | active | Dec 2027 |
| VOMIKIND-MD 4 Orally disintegrating tablets | 🇰🇪Kenya | MANKIND PHARMA LTD. | active | Dec 2027 |
| Onsett 4 Tablet | 🇳🇬Nigeria | Interpharma Industries Limited | active | Sept 2027 |
| Onsett Injection | 🇳🇬Nigeria | Interpharma Industries Limited | active | Sept 2027 |
| Onsett 8 Tablet | 🇳🇬Nigeria | Interpharma Industries Limited | active | Sept 2027 |
| Vomito 4mg Buccal Tablet | 🇰🇪Kenya | Sai Pharmaceuticals Limited | active | Feb 2027 |
| Vomito 8mg Orally disintegrating tablets | 🇰🇪Kenya | Sai Pharmaceuticals Limited | active | Feb 2027 |
| SETRONAX 8MG/4ML SOLUTION INJECTABLE FLACON DE 4ML | 🇨🇮Côte d'Ivoire | STRIDES PHARMA SCIENCE LIMITED | active | Oct 2026 |
| VOMIKIND-MD 8 Orally disintegrating tablets | 🇰🇪Kenya | MANKIND PHARMA LTD. | active | Sept 2026 |
| Ondansetrone Injection Solution for injection/infusion | 🇳🇬Nigeria | Excel Charis Pharmaceutical Chemical Limited | active | Aug 2026 |
| EMITINO Oral Solution | 🇷🇼Rwanda | CACHET PHARMACEUTICALS PVT. LTD | expired | Jun 2026 |
| EMITINO TABLETS Tablets | 🇷🇼Rwanda | CACHET PHARMACEUTICALS PVT. LTD | expired | Jun 2026 |
| ZOFRAN ZYDIS 8 mg | 🇿🇦South Africa | Sandoz South Africa (Pty) Ltd | suspended | Aug 2025 |
| ZOFRAN ZYDIS 4 mg | 🇿🇦South Africa | Sandoz South Africa (Pty) Ltd | suspended | Aug 2025 |
Showing 50 of 153 registrations. Sign up free to search and export all.
ONDANSETRON in Africa — Regulatory Overview
ONDANSETRON is registered across 13 African markets with 153 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Uganda, Morocco, Ghana, South Africa and 9 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 153 registrations, 133 (87%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.